Sanofi Settles Lawsuit Enabling Rival To Lantus Insulin

TRENTON, N.J. (AP) — A less-expensive version of the world's top-selling insulin, Sanofi's Lantus, could go on sale in the U.S. late next year. The French drugmaker Monday settled a lawsuit over patents for Lantus SoloStar, its insulin in a pen-like dispenser.Read more on NewsOK.com

Topics:  trenton   n.j ap    sanofi's lantus   u.s    the french   lantus solostar   newsok    a   lawsuit   insulin   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News